Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2021-02-09 2021-01-20
Drug Identification Number 02390299 02390299
Brand name MYLAN-RILUZOLE MYLAN-RILUZOLE
Common or Proper name RILUZOLE RILUZOLE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RILUZOLE RILUZOLE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60BT 60BT
ATC code N07XX N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2021-03-10 2021-03-10
Actual start date
Estimated end date 2021-04-20 2021-04-20
Actual end date 2021-02-08
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments